GH1 and Parkinson disease: Somatostatin (SST), a growth hormone inhibitory peptide, was found to play an important role in many CNS pathological conditions, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and demyelinating disease (21, 31, 32).